The provocative findings by Pich et al. (Apr. 24 issue)1 showing the influence of tumor-infiltrating clonal hematopoiesis (TI-CH) on patient outcomes in early-stage cancers support the… […]
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumors
Abstract Effective clinical management of patients with cancer requires highly accurate diagnosis, precise therapy selection, and highly sensitive monitoring of disease burden. Caris Assure is… […]
